---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-063521"
form_type: "8-K"
ticker: "ALBT"
cik: "0001630212"
company_name: "Avalon GloboCare Corp."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:40:36.352724+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avalon GloboCare granted Hong Kong patent for CAR-T/CAR-NK cell technology

## Summary
- Hong Kong Intellectual Property Department issued standard patent HK40074322 for CAR-T and CAR-NK cell technology.
- Patent term of 20 years effective February 21, 2020, providing protection through 2040 in Hong Kong.
- Co-developed with strategic partner Arbele Limited; complements existing US and PCT patent protections.
- Technology features bispecific Anti-CD19xCD22 CAR design and localized cytokine induction to enhance efficacy.

## SEC filing metadata
- accession: 0001213900-25-063521
- form_type: 8-K
- ticker: ALBT
- cik: 0001630212
- company_name: Avalon GloboCare Corp.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/0001213900-25-063521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/ea0248802-8k_avalon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-063521
- JSON: https://secwatch.observer/filing/0001213900-25-063521.json
- Plain text: https://secwatch.observer/filing/0001213900-25-063521.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.